Martha E. McGarry - 07 Jun 2024 Form 4 Insider Report for Organon & Co. (OGN)

Reporting relationship: Director
Issuer ticker: OGN
Reported as of: 07 Jun 2024
Net transaction value: +$200,000
SEC form: 4
Accepted by SEC: 11 Jun 2024, 15:16:43 UTC
Prior SEC filing: 13 Jun 2023
Source filing: View source filing
Reporting owner signature: /s/ Tarnetta V. Jones, as Attorney-in-Fact for Martha E. McGarry

Key filing fact

Martha E. McGarry filed Form 4 for Organon & Co. (OGN) on 11 Jun 2024.

Key facts

This page summarizes Martha E. McGarry's Form 4 filing for Organon & Co. (OGN).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 11 Jun 2024, 15:16.

Change

Previous filing in this sequence was filed on 13 Jun 2023.
Current net transaction value: +$200,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

OGN transaction Derivative

Phantom Stock

Award

Transaction value: $200,000
Shares: +9,639
Change %: +36%
Price: $20.75
Shares after: 36,455
Date: 07 Jun 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 9,639
Exercise price
Footnotes: F1, F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Each phantom stock unit is an economic equivalent of one share of Organon & Co. ("Organon") common stock, or 1-for-1.

Footnote F2

Phantom stock units are granted under the Organon Non-Employee Director Savings Plan (the "Plan") and are payable in cash upon settlement after the reporting person's termination of service as a director pursuant to the terms of the Plan.

Footnote F3

Holdings include phantom stock acquired in dividend reinvestment transactions on June 15, 2023, September 14, 2023, December 14, 2023 and March 14, 2024.